171 related articles for article (PubMed ID: 36678929)
1. A New Challenge for the Old Excipient Calcium Carbonate: To Improve the Dissolution Rate of Poorly Soluble Drugs.
Ambrogi V
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678929
[TBL] [Abstract][Full Text] [Related]
2. Use of calcium carbonate as an excipient for release of poorly water soluble drugs: The case of carbamazepine.
Donnadio A; Corneli C; Ricci P; Bini M; Ambrogi V
Int J Pharm; 2020 Nov; 589():119860. PubMed ID: 32911048
[TBL] [Abstract][Full Text] [Related]
3. The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability.
van der Merwe J; Steenekamp J; Steyn D; Hamman J
Pharmaceutics; 2020 Apr; 12(5):. PubMed ID: 32344802
[TBL] [Abstract][Full Text] [Related]
4. Ground Calcium Carbonate as a Low Cost and Biosafety Excipient for Solubility and Dissolution Improvement of Praziquantel.
Borrego-Sánchez A; Sánchez-Espejo R; Albertini B; Passerini N; Cerezo P; Viseras C; Sainz-Díaz CI
Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31615087
[TBL] [Abstract][Full Text] [Related]
5. On the mechanism of solubilization of drugs in the presence of poorly soluble additives.
Boldyrev VV; Shakhtshneider TP; Chizhik SA
Int J Pharm; 2005 May; 295(1-2):177-82. PubMed ID: 15848002
[TBL] [Abstract][Full Text] [Related]
6. Mesoporous calcium carbonate as a phase stabilizer of amorphous celecoxib--an approach to increase the bioavailability of poorly soluble pharmaceutical substances.
Forsgren J; Andersson M; Nilsson P; Mihranyan A
Adv Healthc Mater; 2013 Nov; 2(11):1469-76. PubMed ID: 23703752
[TBL] [Abstract][Full Text] [Related]
7. Drug loading into porous calcium carbonate microparticles by solvent evaporation.
Preisig D; Haid D; Varum FJ; Bravo R; Alles R; Huwyler J; Puchkov M
Eur J Pharm Biopharm; 2014 Aug; 87(3):548-58. PubMed ID: 24568926
[TBL] [Abstract][Full Text] [Related]
8. Application of commercially available mesoporous silica for drug dissolution enhancement in oral drug delivery.
Baumgartner A; Planinšek O
Eur J Pharm Sci; 2021 Dec; 167():106015. PubMed ID: 34547382
[TBL] [Abstract][Full Text] [Related]
9. Exploring the potential of solid dispersion for improving solubility, dissolution & bioavailability of herbal extracts, enriched fractions, and bioactives.
Mohapatra D; Agrawal AK; Sahu AN
J Microencapsul; 2021; 38(7-8):594-612. PubMed ID: 34338596
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs.
Zhang X; Xing H; Zhao Y; Ma Z
Pharmaceutics; 2018 Jun; 10(3):. PubMed ID: 29937483
[TBL] [Abstract][Full Text] [Related]
11. [Solid State NMR Investigation for Molecular States of Specialized Formulation to Improve the Water Solubility of Poorly Water-soluble Drugs].
Higashi K
Yakugaku Zasshi; 2021; 141(9):1063-1069. PubMed ID: 34471007
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the Pore Structure of Functionalized Calcium Carbonate Tablets by Terahertz Time-Domain Spectroscopy and X-Ray Computed Microtomography.
Markl D; Wang P; Ridgway C; Karttunen AP; Chakraborty M; Bawuah P; Pääkkönen P; Gane P; Ketolainen J; Peiponen KE; Zeitler JA
J Pharm Sci; 2017 Jun; 106(6):1586-1595. PubMed ID: 28267446
[TBL] [Abstract][Full Text] [Related]
13. Development of controlled release amorphous solid dispersions (CRASD) using polyvinyl acetate-based release retarding materials: Effect of dosage form design.
Lugtu-Pe JA; Ghaffari A; Chen K; Kane A; Wu XY
Eur J Pharm Sci; 2018 Nov; 124():319-327. PubMed ID: 30194980
[TBL] [Abstract][Full Text] [Related]
14. Floating gastroretentive drug delivery systems: Comparison of experimental and simulated dissolution profiles and floatation behavior.
Eberle VA; Schoelkopf J; Gane PA; Alles R; Huwyler J; Puchkov M
Eur J Pharm Sci; 2014 Jul; 58():34-43. PubMed ID: 24704154
[TBL] [Abstract][Full Text] [Related]
15. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
[TBL] [Abstract][Full Text] [Related]
16. Microstructural effects in drug release by solid and cellular polymeric dosage forms: A comparative study.
Blaesi AH; Saka N
Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():715-727. PubMed ID: 28866221
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutical implications of excipient variability on drug dissolution from immediate release products.
Zarmpi P; Flanagan T; Meehan E; Mann J; Østergaard J; Fotaki N
Eur J Pharm Biopharm; 2020 Sep; 154():195-209. PubMed ID: 32681966
[TBL] [Abstract][Full Text] [Related]
18. Surface dissolution UV imaging for characterization of superdisintegrants and their impact on drug dissolution.
Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
Int J Pharm; 2020 Mar; 577():119080. PubMed ID: 31988030
[TBL] [Abstract][Full Text] [Related]
19. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
[TBL] [Abstract][Full Text] [Related]
20. Development of co-processed excipients in the design and evaluation of atorvastatin calcium tablets by direct compression method.
Pusapati RT; Kumar MK; Rapeti SS; Murthy T
Int J Pharm Investig; 2014 Apr; 4(2):102-6. PubMed ID: 25006555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
